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Introduction
It has been suggested that, for the treatment of anaerobic
infections, antibacterial drugs with anaerobic bacterial
spectra be selected based on the clinical characteristics of
anaerobic infections. Although this approach (as a measure
to counter anaerobic infections) is realistic, the problem is
that there are only a few cases in which causative bacteria
are actually conﬁrmed.
It is generally believed that the rate of isolation of
anaerobes in blood culture is higher in the surgery than in
the internal medicine ﬁeld, because anaerobes are fre-
quently correlated with iatrogenic damage at mucosal sites
during surgery, as these are sites at which anaerobes are
resident ﬂora. It has become clear that transient anaerobic
bacteremia unavoidably develops during operations
involving the internal oral cavity, gastrointestinal tract and
parturient canal.
These sites of infections frequently play the role of
gateways to invasion by anaerobic bacteria via blood ﬂow.
Therefore, when a distinct infectious lesion is conﬁrmed at
certain sites in the body, causative bacteria in blood stream
infections can be estimated to some degree with reference
to information about bacterial ﬂora of the mucosa in the
vicinity of the lesion. However, considering together all the
cases reported in past studies, this gateway to invasion is
indistinct in many cases [1].
According to reports on the analysis of treating anaer-
obic bacteremia before clariﬁcation of the results of blood
culture in patients diagnosed as having had anaerobic
bacteremia from the results of blood culture, there were
many cases in which, at the time of clariﬁcation of
anaerobic bacteremia, treatment with antibacterial drugs,
which do not cover anaerobic bacteria adequately, was
undertaken. It has also become clear that many doctors do
not change antibacterial drugs even after anaerobes have
been isolated from the blood [2].
Some investigators were concerned about these condi-
tions, and recently conducted a prospective study of
patients with Bacteroides bacteremia. The results revealed
that in vitro antibacterial activity of antibacterial drugs
against Bacteroides to correlate well with clinical effects
and that a delay in starting appropriate treatment has a
major inﬂuence on the patient’s outcome [3].
Therefore, more appropriate measures to counter anaer-
obic bacteremia on the basis of starting empiric therapy
using appropriate antibacterial drugs, which takes into
consideration anaerobic bacteria, and blood culture imple-
mentation and conﬁrmation of causative bacteria from the
blood culture results and those of conﬁrmation are needed
for patients with a high possibility of anaerobic bacteremia.
Incidence of blood stream infections with anaerobic
bacteria
The incidence of anaerobic bacteremia is inﬂuenced by the
abilities of laboratories to perform bacteriological tests,
differences in background factors among patients who visit
the institutions afﬁliated with these laboratories, and doc-
tors’ attitudes toward the management of anaerobic bac-
teremia (the frequency of blood culture). Combining the
cases reported in past studies, the incidence of anaerobic
bacteremia is within the 0.5–13% range for specimens
positive by blood culture, accounting for 5–10 per 1,000
inpatients [4].
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Bacteriological assessment of anaerobic bacteremia
According to the blood culture results (in 20,456 culture-
positive cases) at the Mayo Clinic, between 1984 and 1992,
anaerobic bacteria were detected in 920 cases. This fre-
quency of detection ranked the 6th; the frequency for
Staphylococcus aureus (3,518 cases) was highest, followed
by Escherichia coli (2,522), Candida albicans (1,983),
Pseudomonas aeruginosa (1,204), Enterococcus faecalis
(971) and ﬁnally anaerobes. The frequencies for Staphy-
lococcus (813), Streptococcus pneumoniae (pneumococ-
cus) (658) and Enterobacter cloacae (556) were lower than
that for anaerobes [5].
Criteria for selection of antibacterial drugs
for treatment of blood stream infections
in which anaerobic bacteria were suspected
or conﬁrmed to be involved
Empiric therapy
It has been shown that the outcomes of anaerobic bacteremia
patients correlate well with the results of drug sensitivity test
for isolates from infectious lesions, other than blood.
Therefore, if certain antibacterial drug sensitivity test results
for isolates from the observed infectious lesions at other sites
in the patient were to be obtained, the results could be used
as a reference. It has been shown that the results of drug
sensitivity tests are extremely useful (speciﬁcity 97%;
positive predictive value 82%) in patients in whom Bacte-
roides were isolated from blood [3]. Empiric therapy with
antibacterial drugs (e.g., carbapenems, b-lactams with b-
lactamase inhibitors, and others), which takes into consid-
eration the presence of Bacteroides, is thus essential
(Table 1).
Targeted therapy
After determining the causative bacteria, appropriate anti-
bacterial drugs are selected based on the results of drug
sensitivity testing. If antibacterial drug sensitivity test
results for isolates from infectious lesions at other sites
were to be obtained, they could serve as a reference for
targeted therapy using antibacterial drugs (e.g., CLDM and
cephamycins).
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Table 1 Bacterial species of
anaerobic isolates from blood
a Species related to foreign
bodies such as artiﬁcial joints
have become an issue
b It must be noted that
approximately half of the
species are contaminants
Bacteroides species Eggerthella species
B. fragilis E. lenta
B. fragilis group excluding B. fragilis E. sinensis
Pigmented Prevotella species Propionibacterium species
P. intermedia P. acnesa
Non-pigmented Prevotella species Actinomyces species
P. oris Anaerobic gram-positive cocci
P. buccae Peptostreptococcus species
Porphyromonas asaccharolytica Parvimonas micra
Fusobacterium species Finegoldia magna
F. nucleatum Anaerococcus species
F. necrophorum Peptoniphilus species
F. varium/mortiferum group Leptotrichia species
Desulfovibrio species L. buccalis
D. desulfuricans L. hongkongensis
D. piger L. goodfellowii
Clostridium species Sneathia species
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